About Network Immunology

Network Immunology Inc. is a privately held Vancouver-based preclinical stage biotechnology company focused on discovering and developing novel therapies for inflammatory diseases.

Network Immunology creates lasting value through pioneering research in the field of immunology which leads to new product concepts, product development, and finally to the licensing and commercialization of those products and associated intellectual property.


The mission of Network Immunology is to enhance the quality of human and animal lives through the discovery, development and licensing of patented immuno-therapeutics.


Network Immunology has collaborators at several North American universities.

Corporate Updates

Captcha Image